- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Next generation of immune checkpoint inhibitors and beyond ; volume:14 ; number:1 ; day:19 ; month:3 ; year:2021 ; pages:1-29 ; date:12.2021
Journal of hematology & oncology ; 14, Heft 1 (19.3.2021), 1-29, 12.2021
- Urheber
-
Marin-Acevedo, Julian A.
Kimbrough, ErinMarie O.
Lou, Yanyan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-021-01056-8
- URN
-
urn:nbn:de:101:1-2021050520393165188588
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Marin-Acevedo, Julian A.
- Kimbrough, ErinMarie O.
- Lou, Yanyan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cancer immunotherapy beyond immune checkpoint inhibitors
Resistance to immune checkpoint inhibitors. Next steps and combinational approaches
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint inhibitor-related acral vasculitis
Thyroid disorders induced by immune checkpoint inhibitors
Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie
Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
Cardiotoxicity risk factors with immune checkpoint inhibitors
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Neurotoxicities associated with immune checkpoint inhibitor therapy
Cancer immunotherapy beyond immune checkpoint inhibitors
Resistance to immune checkpoint inhibitors. Next steps and combinational approaches
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint inhibitor-related acral vasculitis
Thyroid disorders induced by immune checkpoint inhibitors
Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie
Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
Cardiotoxicity risk factors with immune checkpoint inhibitors
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Neurotoxicities associated with immune checkpoint inhibitor therapy
Cancer immunotherapy beyond immune checkpoint inhibitors
Resistance to immune checkpoint inhibitors. Next steps and combinational approaches
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint inhibitor-related acral vasculitis
Thyroid disorders induced by immune checkpoint inhibitors
Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie
Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
Cardiotoxicity risk factors with immune checkpoint inhibitors
Immune checkpoint inhibitors for multiple myeloma immunotherapy